{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-036742","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2026-08-10T12:00:30+00:00","discovered_at":"2026-08-10T12:05:02.385095+00:00","generated_at":"2026-08-10T12:05:47.436466+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Telomir publishes peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in TNBC and prostate models","bullets":["Telomir-Zn inhibits KDM histone demethylases by depleting intracellular iron; iron-rescue experiments confirmed mechanism specificity in TNBC cells.","In HCC1806 TNBC xenografts, Telomir-Zn significantly reduced metastatic dissemination; combined with paclitaxel in BT-549 models showed synergistic tumor reduction.","In prostate cancer model, oral Telomir-Zn reactivated silenced tumor-suppressor genes STAT1, GSTP1, RASSF1A, CDKN2A, and MASPIN.","Selective killing: TNBC cancer cells killed at low concentrations while normal cells unharmed at >50-fold higher concentrations; MDA-MB-231 xenografts did not respond.","Data supports planned Phase 1/2 TNBC trial under active FDA IND; CEO Erez Aminov cites limited options for advanced TNBC patients."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-036742","json":"https://secwatch.observer/filing/0001493152-26-036742.json","markdown":"https://secwatch.observer/filing/0001493152-26-036742.md","text":"https://secwatch.observer/filing/0001493152-26-036742.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226036742/0001493152-26-036742-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226036742/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T12:05:47.436466+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}